Pacira BioSciences, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pacira BioSciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Pacira BioSciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $12.5M, a 14.3% increase year-over-year.
  • Pacira BioSciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $50.6M, a 4.81% increase year-over-year.
  • Pacira BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $47.9M, a 0.41% decline from 2022.
  • Pacira BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $48.1M, a 13.8% increase from 2021.
  • Pacira BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $42.2M, a 5.83% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $47.9M -$197K -0.41% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $48.1M +$5.85M +13.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $42.2M +$2.33M +5.83% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $39.9M +$6.27M +18.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $33.7M +$1.93M +6.07% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $31.7M +$124K +0.39% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $31.6M +$353K +1.13% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $31.2M -$2.12M -6.35% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $33.4M +$8.55M +34.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-28
2014 $24.8M +$13.3M +116% Jan 1, 2014 Dec 31, 2014 10-K 2016-02-25
2013 $11.5M +$6.74M +141% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-25
2012 $4.78M +$2.28M +91.6% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-24
2011 $2.49M +$2.47M +10739% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-25
2010 $23K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.